Reduced SMAD7 leads to overactivation of TGF-beta signaling in MDS that can be reversed by a specific inhibitor of TGF-beta receptor I kinase.
第一作者:
Li,Zhou
第一单位:
Albert Einstein College of Medicine, Bronx, New York 10461, USA.
作者:
医学主题词
贫血(Anemia);血细胞生成(Hematopoiesis);造血干细胞(Hematopoietic Stem Cells);人类(Humans);K562细胞(K562 Cells);骨髓增生异常综合征(Myelodysplastic Syndromes);蛋白激酶抑制剂(Protein Kinase Inhibitors);吡唑类(Pyrazoles);喹啉类(Quinolines);受体, 转化生长因子β(Receptors, Transforming Growth Factor beta);信号传导(Signal Transduction);Smad7蛋白质(Smad7 Protein);转化生长因子β(Transforming Growth Factor beta)
DOI
10.1158/0008-5472.CAN-10-2933
PMID
21189329
发布时间
2025-05-29
- 浏览61
Cancer research
955-63页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



